The mission of the role is to aid our technical team in developing early-stage techno-economic assessments (TEA) for potential mining and mineral processing solutions being developed at Allonnia. Join us as we develop novel approaches for ore beneficiation, waste valorization and upcycling, and capturing REEs from untapped resources.

The mission of the Analytical Scientist position is to help establish and lead Allonnia’s analytical platform. This scientist will help develop and run EPA Methods 537, 537.1 and draft Method 1633 for PFAS analysis as well as play a key role in helping Allonnia bring transformative, biological solutions to environmental challenges. Other analytical experience of interest includes HPLC, TOC, and XRF.

Our mission at Asimov is to advance humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We're developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics.

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.

The Cell Engineering Business Development team focuses on exploring and expanding the applications of Ginkgo’s platform in Nutrition & Wellness, Agriculture and various Industrial sectors. We build partnerships that reflect the business objectives. The business development team is an integral part of a cross-functional team, including marketing, technical, deal transaction, IP and legal teams, that drive collaborations from conception, through negotiation and, ultimately, to signing and hand-off for implementation.

Ginkgo believes that if we are to grow a thriving, sustainable bioeconomy, we must also grow a new market in biosecurity. Our biosecurity and public health initiative, Concentric by Ginkgo, launched a nationwide emergency response to the COVID-19 pandemic, providing end-to-end pathogen monitoring services to schools, communities, and travelers. As we continue to scale Concentric, our work is also evolving into new and exciting directions, from global expansion to the integration of new technologies and capabilities, including our Traveler-Based Genomic Surveillance Plan with the CDC.

Please reference Job number 21153.82 in your application

Ginkgo is continuously crossing new frontiers of biological engineering and we have a record of delivering what was, until recently, thought impossible. Now, our expansion into mammalian cell engineering promises to push our boundaries even further, and so we’re looking for pioneering engineers to make Ginkgo’s new mammalian cell foundry a success.

Ginkgo is continuously crossing new frontiers of biological engineering, and we have a record of delivering to our partners what was (until recently) thought impossible. Now, our expansion into mammalian cell engineering promises to push our boundaries even further, and so we’re looking for curious, creative, and driven pioneers in this field.

Ginkgo believes that if we are to grow a thriving, sustainable bioeconomy, we must also grow a new market in biosecurity. Our biosecurity and public health initiative, Concentric by Ginkgo, launched a nationwide emergency response to the COVID-19 pandemic, providing end-to-end pathogen monitoring services to schools, communities, and travelers. As we continue to scale Concentric, our work is also evolving into new and exciting directions, from global expansion to the integration of new technologies and capabilities, including our Traveler-Based Genomic Surveillance Plan with the CDC.

Ginkgo is a large multinational public company with operations in the US and Europe. As such Ginkgo Finance is entering its next phase as a public company on this very exciting journey of rapid growth and industry-disrupting technologies. Having gone public in Q4’21, Ginkgo has completed its first full year as a large accelerated public company and completed its first year under the Sarbanes Oxley Act provisions. Ginkgo’s Internal Audit and Compliance Department was formally established in Q4’22. We are looking for talented, dynamic, multi-faceted and dedicated individuals to help build a best-in-class Internal Audit and Compliance Department that is both a trusted advisor to the business but also an objective and independent source of truth for leadership.

Ginkgo believes that if we are to grow a thriving, sustainable bioeconomy, we must also grow a new market in biosecurity. Our biosecurity and public health initiative, Concentric by Ginkgo, launched a nationwide emergency response to the COVID-19 pandemic, providing end-to-end pathogen monitoring services to schools, communities, and travelers. As we continue to scale Concentric, our work is also evolving into new and exciting directions, from global expansion to the integration of new technologies and capabilities, including our Traveler-Based Genomic Surveillance Plan with the CDC.

Ginkgo is continuously crossing new frontiers of biological engineering, and we have a record of delivering to our partners what was (until recently) thought impossible. Now, our expansion into mammalian cell engineering promises to push our boundaries even further, and so we’re looking for curious, creative, and driven pioneers in this field.

Ginkgo is a partner driven company with over 100 programs running on the platform. We are seeking to enable drug-developers but have no designs to develop therapeutics ourselves. Within Ginkgo, the Mammalian Engineering team consists of a set of scientists and engineers with subject matter expertise across cell therapy, gene therapy, RNA therapeutics, and biologics. This team is responsible for translating challenges our partners have into actionable R&D programs that leverage the broader Ginkgo platform’s resources (aka the Foundry); and then manage and execute on those programs to deliver solutions on time and budget. Ginkgo has a number of public and confidential programs in gene therapy, including but not limited to , AAV capsid engineering with Selecta Bio and improving strength and tissue specificity of promoters in GTx applications. We have also invested in novel promoter screening technology through and AAV capsids through for capsid discovery and engineering. As a partner-driven platform company we are not married to one modality and are generally interested in enabling any partner’s delivery strategy provided that engineering biology will help move the needle forward.

We are seeking a metabolomics scientist who will be a key contributor in the area of Natural Product Chemistry in the Chemistry group and provide expertise in the area of Metabolomics and Mass Spectrometry based structure elucidation. This position focuses on acquiring and analyzing metabolomics data from microbial samples, including developing novel methods and workflows and assisting in the development of computational pipelines for data analysis. #LI-LS1

Ginkgo Finance is entering its next phase as a public company on this very exciting journey of rapid growth and industry-disrupting technologies. Now that Ginkgo has completed its public offering (Q4 2021), adopted two impactful accounting standards (CECL and Leasing, 2022) and finished its first year as a large-accelerated filer subject to reporting of our internal controls over financial reporting (2022), the Accounting, Reporting & Controllership (ARC) organization is campaigning to in-source senior level expertise across various disciplines which had been previously outsourced.

In this role you will be responsible for ensuring the success of the Accounts Payable Process at Ginkgo. This role will be responsible for all Accounts Payable processes for Ginkgo and its subsidiaries.

Ginkgo believes that if we are to grow a thriving, sustainable bioeconomy, we must also grow a new market in biosecurity. Our biosecurity and public health initiative, Concentric by Ginkgo, launched a nationwide emergency response to the COVID-19 pandemic, providing end-to-end pathogen monitoring services to schools, communities, and travelers. As we continue to scale Concentric, our work is also evolving into new and exciting directions, from global expansion to the integration of new technologies and capabilities, including our Traveler-Based Genomic Surveillance Plan with the CDC.

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.

Ginkgo Finance is entering its next phase as a public company on this very exciting journey of rapid growth and industry-disrupting technologies. Now that Ginkgo has completed its public offering (Q4 2021), adopted two impactful accounting standards (CECL and Leasing, 2022) and finished its first year as a large-accelerated filer subject to reporting of our internal controls over financial reporting (2022), the Accounting, Reporting & Controllership (ARC) organization is campaigning to in-source senior level expertise across various disciplines which had been previously outsourced.

Ginkgo believes that if we are to grow a thriving, sustainable bioeconomy, we must also grow a new market in biosecurity. Our biosecurity and public health initiative, Concentric by Ginkgo, launched a nationwide emergency response to the COVID-19 pandemic, providing end-to-end pathogen monitoring services to schools, communities, and travelers. As we continue to scale Concentric, our work is also evolving into new and exciting directions, from global expansion to the integration of new technologies and capabilities, including our Traveler-Based Genomic Surveillance Plan with the CDC.

Core to our organism engineering pipeline is the testing and analysis of our engineered strains, using state-of-the-art analytical and automation technologies. We’re looking for highly talented and motivated associates to join our high-throughput screening (HTS) operations team to help carry out these critical functions. With your demonstrated ability to evolve a process in response to changing technology and demands, and your desire for quality output, you will provide essential operational support to HTS through culturing services, sample preparation, and screen execution while ensuring quality data delivery to a cross-functional set of Ginkgo teams. #LI-LS1

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.

Pharma Business Development team focuses on exploring the applications of Ginkgo’s platform in the therapeutics and vaccines space, and building partnerships that reflect the business objectives. The business development team is an integral part of a cross-functional team, including Growth, technical, deal transaction, IP and legal teams, that drive collaborations from conception, through negotiation and, ultimately, to signing.

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms. Today, our foundry is developing over 40 different organisms to make different products across multiple industries.

Ginkgo's NGS group enables diverse synthetic biology projects by providing sequencing services to organism engineering teams. Our services include DNA and RNA sequencing using short read (Illumina) and long read (PacBio and Oxford Nanopore) platforms. We confirm synthetic constructs, genomic edits, and expression profiles of engineered organisms. We help develop the next generation of therapeutics in RNA and gene therapy.

Ginkgo believes that if we are to grow a thriving, sustainable bioeconomy, we must also grow a new market in biosecurity. Our biosecurity and public health initiative, Concentric by Ginkgo, launched a nationwide emergency response to the COVID-19 pandemic, providing end-to-end pathogen monitoring services to schools, communities, and travelers. As we continue to scale Concentric, our work is also evolving into new and exciting directions, from global expansion to the integration of new technologies and capabilities, including our Traveler-Based Genomic Surveillance Plan with the CDC.

Downstream Process Development at Amyris is rapidly increasing in scope as we continue to diversify our portfolio of industrial bioproducts. We are looking for a dynamic and creative engineer who will help us implement the equipment, automation, and software tools necessary to scale our DSP trains, support transfer to manufacturing, monitor and respond to process performance at scale, and drive continuous process improvement. In addition to being a subject matter expert in downstream separations processes, the successful candidate will be expected to mentor early career process engineers who are focusing on validating new separations trains at pilot scale.

The mission of the Environmental Engineer is to help drive new technology adoption in the market, including customizing it to specific market applications. This hands-on engineer would serve as Allonnia’s subject matter expert on field installation, startup and commissioning, system design support, technology capabilities, and performance expectations for new remediation products in a variety of media and applications. The overall scope of this role will enable our newest engineer to have an opportunity to become an expert on cutting edge technologies that will address some of the most challenging environmental contaminants that threaten human and ecological health.

The Mission of this position is to be the wing-to-wing owner of the Allonnia SAFF product line. This employee will work with partners, vendors, and suppliers on the front end to ensure that our SAFF units are being delivered in an efficient, professional manner. This employee will ensure that all SAFF operations are running to the Allonnia standard. This employee will work with his/her commercial peers on the proper placement of SAFF units and execution of after-sale.

Pharma Business Development team focuses on exploring the applications of Ginkgo’s platform in the therapeutics and vaccines space, and building partnerships that reflect the business objectives. The business development team is an integral part of a cross-functional team, including Growth, technical, deal transaction, IP and legal teams, that drive collaborations from conception, through negotiation and, ultimately, to signing.

Your role will be to: grow and test various fungi and bacteria; test the capability of environmental microbes to degrade / detoxify various environmental contaminants in support of developing commercial products; use environmental microbes to valorize waste and develop molecular biology tools to support protein engineering/expression based projects. This is a full-time position that requires 85% time in the lab and 15% time for project management, data analysis, and reporting.

As Ginkgo enters a phase where demand for our services has never been higher, we are building a Transformation function with the mandate to identify and execute on the critical initiatives across the company that will enable us to scale and meet our Mission of Making Biology Easier to Engineer.

We are seeking a to join our team in Boston, MA and help push the boundaries of mammalian synthetic biology. This role is for a hands-on technical leader on our team, who will perform in-depth mass-spec and biophysical characterization across multiple modalities, such as biologics and viral vector therapies, and help establish and grow Asimov’s analytical sciences team.

We seek to hire a highly motivated Protein Scientist to join the Microbial Engineering Division at Colorifix. The successful candidate will be a pivotal member of a multidisciplinary, creative, and dedicated team focused on the development of heterologous natural pigment pathways in industrially relevant microorganisms for application at scale in the textile industry. You will bring your knowledge and experience in protein biology to strengthen the colour development pipeline. The Microbial Engineering team is looking for a candidate who enjoys multi-disciplinary teamwork, taking on challenges, shows creativity, flexibility, enthusiasm, and excellent communication skills.

As Ginkgo enters a phase where demand for our services have never been higher, we are building a new Operations function with the mandate to drive “scale” across the organization. Specifically, economies of scale at Ginkgo can be observed empirically from a relationship they refer to as “Knight’s Law” (loosely inspired by Moore’s Law for semiconductors). Since 2015, Ginkgo has witnessed an exponential increase in output (3x biological tests per year) alongside an exponential decline (50% reduction) in the average cost per test. To help continue this impressive trend, Ginkgo is building a Continuous Improvement & Industrial Engineering (CI/IE) team within the Operations function. This team will design and implement new tools, methods, and operating models necessary to further unlock the scale growth needed to achieve our long-term financial, operational, and commercial goals.

Pharma Business Development team focuses on exploring the applications of Ginkgo’s platform in the therapeutics and vaccines space, and building partnerships that reflect the business objectives. The business development team is an integral part of a cross-functional team, including Growth, technical, deal transaction, IP and legal teams, that drive collaborations from conception, through negotiation and, ultimately, to signing.

We're building a computer-aided design (CAD) platform to engineer cells, and we're looking for a Senior Product Manager to lead its development. Our goal is to create better design tools for bioengineers. This includes quantitative design of genetic functions, distilling insight from multiomics “debugging” data, and machine learning-based simulation of biological systems. The ideal candidate has deep domain expertise in launching scientific software products for the life sciences.

We're seeking a full-time Scientist/Senior Scientist, Protein Design to join our team in Boston, MA. The ideal candidate will have a proven track record of building and applying diverse models to capture and predict the relationship between sequence and function, in order to design proteins with new properties. This role will be a key contributor to our team, contributing to the development of new tools for genetic engineering. They will also work closely with Asimov’s world-class synthetic biology and high-throughput experimentation teams. This is a unique opportunity to work at a nimble, forward-thinking synthetic biology startup and help build the future of biological engineering.

We are searching for a Computational Biologist with deep domain experience in multiomics analysis to join our team. At Asimov, data is core to our platform. We genetically engineer living cells and refine our designs using high-dimensional NGS data using RNA-seq, ATAC-seq, ribosome profiling, genome sequencing, and more. The ideal candidate is motivated by designing complex cellular systems and distilling insight from large biological datasets. This is a unique opportunity to work at a nimble, forward-thinking synthetic biology startup and help build the foundation for engineering biology.

The Protein Engineering Team works to address the complex challenges of enzyme discovery, characterization, and engineering. We utilize state-of-the-art bioinformatics to discover novel enzymes and employ a growing suite of computational protein design tools for rationally designing improvements.

Pharma Business Development team focuses on exploring the applications of Ginkgo’s platform in the therapeutics and vaccines space, and building partnerships that reflect the business objectives. The business development team is an integral part of a cross-functional team, including Growth, technical, deal transaction, IP and legal teams, that drive collaborations from conception, through negotiation and, ultimately, to signing.

Colorifix has a unique operational and business model. Therefore, we like to build our own bespoke software tools to help the business run. We are looking for a full-stack developer to join our team and help us build data and content management platforms.

Colorifix has a unique operation and business model. Therefore, we like to build our own bespoke software tools to help the business run. We are looking for a back-stack developer to join our team and help us build data and content management platforms. You will be working in collaboration with data scientists, engineers and the implementation team to develop simple and flexible solutions for interaction with our clients and staff.